A combination of an SGLT-2 inhibitor drug and a moderately calorie-restrictive diet leads to higher rates of type 2 diabetes ...

(Reuters) - Novo Nordisk said on Tuesday the U.S. FDA has approved its diabetes drug Ozempic to reduce the risk of worsening ...

Ozempic's expanded approval in the U.S. could transform how doctors treat patients with the condition, which involves a ...

New research shows diabetes medication SGLT-2 inhibitors lower dementia risk by up to 35%, offering hope for millions ...

A recent study suggests that type 2 diabetes can be reversed through a combination of calorie reduction, physical activity, ...

Chronic kidney disease affects about 37 million adults in the United States and is expected to rise. It is a common ...

The FDA has approved a new indication for semaglutide to lower the risk for worsening kidney disease, kidney failure and ...

FRIDAY, Jan. 24, 2025 (HealthDay News) -- People can reverse their type 2 diabetes through a combination of calorie cutting ...

The Kokomo woman was pre-diabetic when she asked her doctor about Ozempic, the popular anti-diabetic drug. Usually prescribed ...

Glucagon-like peptide 1 receptor agonists (GLP1RA)-medications for type 2 diabetes and obesity that have recently been making headlines due to a rise in popularity as weight loss agents-have been ...

A groundbreaking medication capable of preventing type 2 diabetes by up to 85% is offering new hope to those at risk, a ...